GlaxoSmithKline Manufacturing S.p.A. (manufacturing, primary and secondary packaging, quality control, batch release of powder and secondary packaging, quality control and batch release of solvent)

The drug is used to treat multiple myeloma, late-stage ovarian carcinoma, neuroblastoma (stage IV in children), as well as localized melanoma and soft tissue sarcoma of the limbs (via regional perfusion).

Dosage form: powder for injection solution

ATC: L01AA03